Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review
Yurong Xiang,Xiaobin Luo
DOI: https://doi.org/10.2147/copd.s447739
2024-02-29
International Journal of COPD
Abstract:Yurong Xiang, 1, &ast Xiaobin Luo 2, &ast 1 School of Medical and Life Science, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610000, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaobin Luo, Department of Respiratory and Critical Care Medicine, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China, Tel +86-18008258560, Email Most patients with chronic obstructive pulmonary disease (COPD) suffer from at least one additional, clinically relevant chronic disease. To a degree, the high global prevalence and mortality rate of COPD is closely related to its extrapulmonary effects. Moreover, the various of comorbidities of COPD and itself interact with each other, resulting in diverse clinical manifestations and individual differences, and thus further influencing the prognosis as well as healthcare burden of COPD patients. This is closely related to the common risk factors of chronic diseases (aging, smoking, inactivity, etc.). Additionally, some pathophysiological mechanisms caused by COPD, including the systemic inflammatory response, hypoxia, oxidative stress, and others, also have an impact on other systems. But comprehensive management and medical interventions have not yet been established. The clinicians should improve their knowledge and skills in diagnosing as well as treating the comorbidities of COPD, and then aim to develop more individualized, efficient diagnostic and therapeutic strategies for different patients to achieve greater clinical benefits. In this article, we will review the risk factors, mechanisms, and treatment strategies for extrapulmonary comorbidities in chronic obstructive pulmonary disease, including cardiovascular diseases, diabetes, anemia, osteoporosis, emotional disorders, and gastroesophageal reflux disease. Keywords: chronic obstructive pulmonary disease, comorbidity, risk factors, therapeutics Chronic obstructive pulmonary disease (COPD) is a common respiratory disease that can be prevented and treated. It primarily involves various airway and/or alveolar abnormalities caused by excessive exposure to the toxic particles or gases, and can result in persistent and progressively worsening chronic respiratory symptoms and airflow limitations. 1 It is estimated that COPD would become the fourth leading cause of premature death by 2040. 2 Meanwhile, COPD is ranked as sixth leading cause of all-age mortality and years of life loss (YLLs) by 2019, and its rank was proportional to the age. 3 The enormous financial burden of COPD is closely related to both itself and its multiple comorbidities. 4 In 2011, the 'comorbidities' were included in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and used for the comprehensive evaluation of COPD. In the 2023 GOLD guidelines, the concept of "heterogeneous lung condition" was proposed, 1 emphasizing the diversity and individual differences in clinical manifestations of COPD patients. The reason for this is that various factors, such as hypoxia, oxidative stress (OS), systemic inflammation and other mechanisms, can lead to damage in multiple organs and tissues throughout the body. These include the cardiovascular, endocrine, hematological, locomotor, neuropsychiatric, and digestive system. 5 The risk of comorbidities in COPD patients is also elevated by factors such as smoking history and advanced age. 6 In addition, several extrapulmonary comorbidities of COPD have been found to considerably increase the risk of acute exacerbation, complicate the treatment, and impose a heavy medical burden on COPD patients. 4,7 Therefore, a comprehensive understanding and early diagnosis of comorbidities are extremely important to optimize the treatment and prognosis of COPD. This review summarizes recent advances in the study of such above extrapulmonary comorbidities in COPD. We conducted a comprehensive search on Medline/PubMed and China national knowledge infrastructure (CNKI) up to December 2023 to identify studies relevant to this review. The combination of the following keywords was used as the potential search terms: "Comorbidities in COPD", "Relationship", "Prevalence", "Risk factors", "Treatment", "Management", "Survival and Quality of Life" and so on. In addition, the reference lists of the retrieved articles were further examined in order to determine their significance to the subject matter of this review. A meta-analysis of observational studies found that the probability of cardiovascular events was significantly increased in pati -Abstract Truncated-
respiratory system